Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

BackgroundDeutetrabenazine is a widely used drug for the treatment of tardive dyskinesia (TD), and post-marketing testing is important. There is a lack of real-world, large-sample safety studies of deutetrabenazine. In this study, a pharmacovigilance analysis of deutetrabenazine was performed based...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanping Shu, Yuanhe Wang, Jiaoying Liu, Lingyan Hu, Sichao Tong, Gang Wu, Xianlin Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1498215/full
Tags: Add Tag
No Tags, Be the first to tag this record!